Abstract
Increased concentrations of circulating metal-degradation products derived from the use of Ti orthopaedic implants may have deleterious biological effects over the long term. Therefore, there is an increasing need to establish the basal level of Ti in the serum of the population (exposed and non-exposed) with appropriate highly sensitive techniques and strategies. With this aim, we have developed a quantitative strategy for the determination of total Ti concentration in human serum samples by isotope dilution analysis using a double-focussing inductively coupled plasma mass spectrometer. Minimizing sample handling and therefore contamination issues, we obtained detection limits of about 0.05 μg L−1 Ti working at medium resolution (m/Δm 4000). Such extremely good sensitivity permitted us to establish the range of Ti concentration in serum of 40 control individuals (mean 0.26 μg L−1) and also to compare it with the level in exposed patients with different Ti metal implants. On the other hand, Ti transport “in vivo” studies have been enabled by online coupling of liquid chromatography (anion-exchange) separation and double-focussing inductively coupled plasma mass spectrometry for sensitive detection of Ti. The development of a postcolumn isotope dilution strategy permitted quantitative characterization of the Ti-transporting biomolecules in human serum. The results for unspiked serum revealed that 99.8% of the Ti present in this fluid is bound to the protein transferrin, with column recoveries greater than 95%.
Similar content being viewed by others
References
Nicholson JW (2002) The chemistry of medical and dental materials. RSC monographs. Royal Society of Chemistry, Cambridge
Lascombes P, Haumont T, Journeau P (2006) J Ped Orthop 26:827–834
Jacobs JJ, Skipor AK, Urban RM, Galante JO (1991) J Bone Joint Surg (Am) 73:1475–1486
Wang JC, Yu WD, Sandhu HS, Betts F, Bhuta S, Delamarter RB (1999) Spine 24:899–903
Hjalmarsson L, Smedberg JI, Wennerberg A (2011) J Oral Rehab 38:61–71
Keegan GM, Learmonth ID, Case CP (2007) J Bone Joint Surg (Br) 89B:567–573
Brien WW, Salvati EA, Betts F, Bullough P, Wright T, Rimnac C, Buly R, Garvin K (1992) Clin Orthop 276:66–74
Jacobs JJ, Skipor AK, Campbell PA, Hallab NJ, Urban RM, Amstutz HC (2004) J Arthroplasty 19:S59–S65
Dustan E, Sanghrajka AP, Tilley S, Unwin P, Blunn G, Cannon SR, Briggs TWR (2005) J Bone Joint Surg (Br) 87:628–631
Chen J, Dong X, Zhao J, Tang G (2009) J App Toxicol 29:330–337
Tinoco AD, Earnes EV, Valentine AM (2008) J Am Chem Soc 130:2262–2270
Sarmiento-González A, Marchante-Gayón JM, Tejerina-Lobo JM, Paz Jiménez J, Sanz-Medel A (2008) Anal Bioanal Chem 391:2583–2589
Richardson TD, Pineda SJ, Strenge KB, Van Fleet TA, McGregor M, Milbrandt JC, Espinosa JA, Freitag P (2008) Spine 33:792–796
Tinoco AD, Valentine AM (2005) J Am Chem Soc 127:11218–11219
Guo M, Sun H, McArdle HJ, Gambling L, Sadler PJ (2000) Biochemistry 39:10023–10033
Sariego Muñiz C, Marchante Gayón JM, García Alonso JI, Sanz-Medel A (1999) J Anal At Spectrom 14:193–198
Rottmann L, Heumann KG (1994) Fresenius J Anal Chem 350:221–227
McGarry S, Morgan SJ, Grosskreuz RM, Williams AE, Smith WR (2008) J Trauma 64:430–433
Patton MS, Lyon TDB, Ashcroft GP (2008) Acta Orthop 79:820–825
Nuevo-Ordóñez Y, Montes-Bayón M, Blanco-González E, Paz-Jiménez J, Tejerina-Lobo JM, Pena-López M, Sanz-Medel A (2009) J Anal At Spectrom 24:1037–1043
Sarmiento A, Marchante Gayon J, Ruiz Encinar J, Sanz-Medel A (2008) Anal Chem 80:8702–8711
Del Castillo ME, Montes-Bayón M, Sanz-Medel A (2006) Anal Chem 82:8218–8226
Acknowledgements
The authors gratefully acknowledge the Regional Government of Asturias (FICYT) for financial support through the projects PC06-035 and PC10-27.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Published in the special issue Plasma Spectrochemistry with guest editors Juan Castillo and Martín Resano.
Rights and permissions
About this article
Cite this article
Nuevo-Ordóñez, Y., Montes-Bayón, M., Blanco-González, E. et al. Titanium release in serum of patients with different bone fixation implants and its interaction with serum biomolecules at physiological levels. Anal Bioanal Chem 401, 2747–2754 (2011). https://doi.org/10.1007/s00216-011-5232-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5232-8